TYK Medicines (HKSE:02410) Institutional Ownership: 6.34% (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02410 TYK Medicines Inc HKSE:02410
7 GF Score
Price HK$2.99
! 3 Warning Signs
View Full Analysis

What is TYK Medicines Institutional Ownership?

TYK Medicines HKSE:02410 +11.38% 7 Institutional Ownership is 6.34% as of Sep. 11, 2026. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TYK Medicines's institutional ownership is 6.34%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TYK Medicines's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TYK Medicines's Float Percentage Of Total Shares Outstanding is 0.00%.

TYK Medicines Institutional Ownership Historical Data

* Premium members only.

The historical data trend for TYK Medicines's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TYK Medicines Institutional Ownership Chart

TYK Medicines Historical Data

The historical data trend for TYK Medicines can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 1.94 5.17 5.17 5.16 5.10 5.10 5.10 6.34 6.34 6.34
HKSE:02410
7GF Score
TYK Medicines Inc HKSE:02410
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TYK Medicines Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 6.34% mean?
TYK Medicines (HKSE:02410) has a Institutional Ownership of 6.34% as of Sep. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TYK Medicines and its competitors.
Is TYK Medicines' Institutional Ownership too high?
TYK Medicines' current Institutional Ownership is 6.34%. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' Institutional Ownership compare to VRTX and REGN?
TYK Medicines' Institutional Ownership of 6.34% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on TYK Medicines and its competitors. TYK Medicines's current Institutional Ownership is 6.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current Institutional Ownership of 6.34%. The current Institutional Ownership is 6.34%. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current Institutional Ownership is 6.34% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TYK Medicines Business Description

Address No.277 Longlan Road, 8th Floor, Building T2, China Eastern Binjiang Center, Xuhui District, Shanghai, CHN
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score

Get the complete analysis for HKSE:02410

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.99
Price